<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Possible drug-drug interactions between SARS-CoV-2 antiviral drugs and commonly used immunosuppressants for liver transplant recipients.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td>
     <inline-graphic xlink:href="fx1_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="sp0015">
   <p>Abbreviations:</p>
  </fn>
  <fn id="sp0020">
   <p>ATV: Atazanavir, LPV/r: Lopinavir/ritonavir, RDV: Remdesivir, FAVI: Favipiravir, CLQ: Chloroquine, HCLQ: Hydroxychloroquine, RBV: Ribavirin, TCZ: Tocilizumab, IFN-β: Interferon beta.</p>
  </fn>
  <fn id="sp0025">
   <p>♥: These drugs have been identified as having a known or possible QT or TdP risk.</p>
  </fn>
  <fn id="sp0030">
   <p>↑ Potential increased exposure of the comedication.</p>
  </fn>
  <fn id="sp0035">
   <p>↓ Potential decreased exposure of the comedication.</p>
  </fn>
  <fn id="sp0040">
   <p>↔ No significant effect</p>
  </fn>
  <fn id="sp0045">
   <p>Boxed color code:</p>
  </fn>
  <fn id="sp0050">
   <p>Black: These drugs should not be coadministered.</p>
  </fn>
  <fn id="sp0055">
   <p>Dark grey: Potential interaction which may require a dose adjustment or close monitoring.</p>
  </fn>
  <fn id="sp0060">
   <p>Light grey: Potential interaction likely to be of weak intensity. Additional action/monitoring or dosage adjustment unlikely to be required.</p>
  </fn>
  <fn id="sp0065">
   <p>White: No clinically significant interaction expected.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
